Low-dose Involved-field Radiation in the Palliation Of Non-Hodgkin Lymphoma: Predictors of Response and Treatment Failure

被引：0
|
作者：
Russo, A. L. [1 ]
Chen, Y. [2 ]
Vinjamoori, A. [3 ]
Martin, N. E. [2 ]
Freedman, A. [2 ]
Michaelson, E. M. [2 ]
Silver, B. [2 ]
Mauch, P. M. [2 ]
Ng, A. K. [2 ]
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.293
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S72 / S73
页数：2
相关论文
共 50 条
  • [21] Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: Optimizing involved-field radiotherapy in transplant patients
    Kahn, ST
    Flowers, CR
    Lechowicz, MJ
    Hollenbach, K
    Johnstone, PAS
    CANCER JOURNAL, 2005, 11 (05): : 425 - 431
  • [22] Effect of deep inspiration breath hold on lung volumes and radiation dose parameters for involved-field radiation of Hodgkin's and non-Hodgkin's lymphomas of the mediastinum
    Graham, D. L.
    Brunet, B.
    Balogh, A. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S640 - S640
  • [23] A Comparison of Involved-Field Radiation Therapy Treatment Outcomes in Pediatric and Young Adult Hodgkin Lymphoma
    Huynh-Le, M.
    Walker, A.
    Wharam, M.
    Priel, I. Paz
    Terezakis, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S600 - S601
  • [24] Local Control after Low-Dose Radiation for Two Rare Forms of Indolent Non-Hodgkin Lymphoma
    Burlile, J. F.
    Saifi, O.
    Laughlin, B.
    Harmsen, W. S.
    Rule, W. G.
    Peterson, J. L.
    Frechette, K. M.
    Durani, U.
    Hampel, P.
    Hoppe, B. S.
    Lester, S. C.
    Breen, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E459 - E459
  • [25] Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma
    Rizzieri, DA
    Sand, GJ
    McGaughey, D
    Moore, JO
    DeCastro, C
    Chao, NJ
    Vredenburgh, JJ
    Gasparetto, C
    Long, GD
    Anderson, E
    Foster, T
    Toaso, B
    Adams, D
    Niedzwiecki, D
    Gockerman, JP
    CANCER, 2004, 100 (11) : 2408 - 2414
  • [26] A Retrospective Analysis of the Efficacy of Low-Dose Metronomic Cyclophosphamide for Treatment in Patients with Low Grade Non-Hodgkin Lymphoma
    Han, Boram
    Kim, Bum Jun
    Kim, Ho Young
    Zang, Dae Young
    Lim, Hyun
    Kang, Ho Suk
    Soh, Jae Seung
    Kim, Hyo Jung
    BLOOD, 2021, 138
  • [27] Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease
    Donaldson, Sarah S.
    Link, Michael P.
    Weinstein, Howard J.
    Rai, Shesh N.
    Brain, Sam
    Billett, Amy L.
    Hurwitz, Craig A.
    Krasin, Matthew
    Kun, Larry E.
    Marcus, Karen C.
    Tarbell, Nancy J.
    Young, Jeffrey A.
    Hudson, Melissa M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) : 332 - 337
  • [28] Outcome of Low-Dose Palliative Radiation Therapy in Relapsed or Refractory High-Grade Non-Hodgkin Lymphoma
    Brady, J. L.
    Attallah, H.
    Mikhaeel, N. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E493 - E493
  • [29] Transition from mantle RT to low-dose involved-field RT: Implications for second cancer risk among Hodgkin's lymphoma survivors
    Koh, ES
    Tran, TH
    Heydarian, M
    Tsang, R
    Pintilie, M
    Gospodarowicz, M
    Sun, A
    Wells, W
    Paul, N
    Hodgson, DC
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S23 - S23
  • [30] Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy
    Nachman, JB
    Sposto, R
    Herzog, P
    Gilchrist, GS
    Wolden, SL
    Thomson, J
    Kadin, ME
    Pattengale, P
    Davis, PC
    Hutchinson, RJ
    White, K
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3765 - 3771
12345